These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3768937)

  • 1. Analysis of free growth and post-treatment regrowth of C3H mammary carcinoma in individual mice.
    Demicheli R; Foroni R; Giuliani F; Savi G
    Cell Tissue Kinet; 1986 Jul; 19(4):471-6. PubMed ID: 3768937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gompertzian re-evaluation of the growth patterns of transplantable mammary tumours in sialoadenectomized mice.
    Bassukas ID
    Cell Prolif; 1994 Apr; 27(4):201-11. PubMed ID: 10465015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tumor growth kinetics on response to doxorubicin treatment of C3H mammary carcinoma.
    Demicheli R; Foroni R; Giuliani FC; Savi G
    Tumori; 1988 Jun; 74(3):269-74. PubMed ID: 3400117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
    Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
    Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor control and regrowth probability after a single radiation of experimental animal tumors.
    Urano M; Fukuda N; Ando K; Koike S; Tanaka N
    J Natl Cancer Inst; 1974 Aug; 53(2):517-25. PubMed ID: 4843276
    [No Abstract]   [Full Text] [Related]  

  • 6. The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma.
    Horsman MR; Khalil AA; Chaplin DJ; Overgaard J
    Acta Oncol; 1995; 34(3):443-6. PubMed ID: 7540025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.
    Rak JW; McEachern D; Miller FR
    Br J Cancer; 1992 May; 65(5):641-8. PubMed ID: 1586590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recursion formula of the Gompertz function: a simple method for the estimation and comparison of tumor growth curves.
    Bassukas ID; Maurer-Schultze B
    Growth Dev Aging; 1988; 52(3):113-22. PubMed ID: 3253243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives.
    Butel JS; Dudley JP; Medina D
    Cancer Res; 1977 Jun; 37(6):1892-900. PubMed ID: 192465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.
    Griffin RJ; Okajima K; Ogawa A; Song CW
    Int J Radiat Biol; 1999 Oct; 75(10):1299-306. PubMed ID: 10549607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a controlled-release cisplatin delivery system used after resection of mammary carcinoma in mice.
    Ehrhart N; Dernell WS; Ehrhart EJ; Hutchison JM; Douple EB; Brekke JH; Straw RC; Withrow SJ
    Am J Vet Res; 1999 Nov; 60(11):1347-51. PubMed ID: 10566806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model for metastatic growth illustrated by in vivo and in vitro growth of a transplantable mammary carcinoma in mice.
    Fuchshuber P; Günther M; Feaux De Lacroix W; Fischer R
    Anticancer Res; 1986; 6(4):819-27. PubMed ID: 2428282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: single fraction heat and drug treatment.
    Monge OR; Rofstad EK; Kaalhus O
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1661-9. PubMed ID: 3145205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data.
    Demicheli R; Foroni R; Ingrosso A; Pratesi G; Soranzo C; Tortoreto M
    Cancer Res; 1989 Dec; 49(23):6543-6. PubMed ID: 2819710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
    Grau C; Zachariae C; Mao HS; Overgaard J
    Acta Oncol; 1990; 29(6):769-74. PubMed ID: 2223148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
    Horsman MR; Christensen KL; Overgaard J
    Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.
    Miller BE; Miller FR; Machemer T; Heppner GH
    Br J Cancer; 1993 Jul; 68(1):18-25. PubMed ID: 8318410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.
    Olive PL; Horsman MR; Grau C; Overgaard J
    Br J Cancer; 1997; 76(6):694-9. PubMed ID: 9310232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea effects in the C3H mouse. II. Mammary tumor cell kinetics.
    Dethlefsen LA; Riley RM
    Cell Tissue Kinet; 1973 Mar; 6(2):173-84. PubMed ID: 4684919
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamic model describing the growth of a mammary carcinoma in the mouse under the influence of adriamycin treatment.
    Dagnino G; Donelli MG; Colombo T; Bertello C; Pacciarini MA; Martini A
    Oncology; 1981; 38(1):53-8. PubMed ID: 7443177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.